Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fibrin drives thromboinflammation and neuropathology in COVID-19
Jae Kyu Ryu, Zhaoqi Yan, Mauricio Montaño, et al.
Nature (2024) Vol. 633, Iss. 8031, pp. 905-913
Open Access | Times Cited: 21

Showing 21 citing articles:

Mechanisms of long COVID and the path toward therapeutics
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 23
Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19
Zhouyi Rong, Hongcheng Mai, Gregor Ebert, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 12, pp. 2112-2130.e10
Open Access | Times Cited: 5
Animal Models of Non-Respiratory, Post-Acute Sequelae of COVID-19
Abigail Vanderheiden, Michael Diamond
Viruses (2025) Vol. 17, Iss. 1, pp. 98-98
Open Access
N-acetylcysteine (NAC) supplementation improves dyspnea and may normalize von Willebrand plasma levels in gynecologic patients with Post-Acute-COVID-Sequela (PASC)/Long COVID
Stefania Bellone, Eric R. Siegel, Alessandro D. Santin
Gynecologic Oncology Reports (2025), pp. 101682-101682
Open Access
Antibodies to PF4 in severe COVID-19: same but different
Philip Choi, Imogen Mitchell
Blood (2025) Vol. 145, Iss. 6, pp. 559-560
Closed Access
Targeting the SARS-CoV-2 reservoir in long COVID
Amy D. Proal, Soo Aleman, Morgane Bomsel, et al.
The Lancet Infectious Diseases (2025)
Closed Access
Retrospective Clinical Investigation into the Association Between Abnormal Blood Clotting, Oral Anticoagulant Therapy, and Medium-Term Mortality in a Cohort of COVID-19 Patients
Giorgia Dinoi, Maria Vittoria Togo, Pietro Guida, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 535-535
Open Access
Adoptive transfer of natural killer cells in therapeutic treatment of COVID-19 patients
Abdulaziz Alamri
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
Biological Significance of the Erythrocyte Sedimentation Rate (ESR) Test: Pandemic Reemergence of Robin Fåhraeus’s “Fibrin Coagula” – Historical Overview
Donald R. Forsdyke
(2025)
Closed Access
Identifying and Validating Prognostic Hyper-Inflammatory and Hypo-Inflammatory COVID-19 Clinical Phenotypes Using Machine Learning Methods
Xiaojing Ji, Yiran Guo, Lujia Tang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3009-3024
Open Access
Health outcomes one year after Omicron infection among 12,789 adults: a community-based cross-sectional study
Hui Zhang, Peng Yang, Xiaoying Gu, et al.
The Lancet Regional Health - Western Pacific (2025), pp. 101507-101507
Open Access
Fibrinaloid microclots in Long COVID: assessing the actual evidence properly
Douglas B. Kell, Asad Khan, Etheresia Pretorius
Research and Practice in Thrombosis and Haemostasis (2024) Vol. 8, Iss. 7, pp. 102566-102566
Open Access | Times Cited: 2
COVID-19 thromboinflammation: adding inflammatory fibrin to the puzzle
Elena Magrini, Cecilia Garlanda
Trends in Immunology (2024)
Closed Access | Times Cited: 2
Pioneering discovery and therapeutics at the brain-vascular-immune interface
Katerina Akassoglou, Dimitrios Davalos, Andrew S. Mendiola, et al.
Cell (2024) Vol. 187, Iss. 21, pp. 5871-5876
Closed Access | Times Cited: 1
Low-Grade Inflammation in Long COVID Syndrome Sustains a Persistent Platelet Activation Associated With Lung Impairment
Marta Brambilla, F Fumoso, Maria Giulia Conti, et al.
JACC Basic to Translational Science (2024) Vol. 10, Iss. 1, pp. 20-39
Open Access | Times Cited: 1
Detrimental Effects of Anti-Nucleocapsid Antibodies in SARS-CoV-2 Infection, Reinfection, and the Post-Acute Sequelae of COVID-19
Emi E. Nakayama, Tatsuo Shioda
Pathogens (2024) Vol. 13, Iss. 12, pp. 1109-1109
Open Access | Times Cited: 1
Machine learning reveals prominent spontaneous behavioral changes and treatment efficacy in humanized and transgenic Alzheimer's disease models
Stephanie R. Miller, Kevin Luxem, Kelli Lauderdale, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114870-114870
Open Access | Times Cited: 1
Unmasking SARS-CoV-2’s coagulation conspiracy: the role of Spike
Tom Aschman, Helena Radbruch
Trends in Immunology (2024)
Open Access
Targeting fibrin in COVID-19
Sarah Crunkhorn
Nature Reviews Drug Discovery (2024)
Closed Access
New Challenges and Perspectives in Neurology and Autonomic Disorders: A Leap Forward
Svetlana Blitshteyn, Ilene S. Ruhoy
Journal of Personalized Medicine (2024) Vol. 14, Iss. 10, pp. 1063-1063
Open Access
COVID-19 Lung Injury: Unique and Familiar Aspects of Pathophysiology
Stefan Hall, Geraint Berger, Christine Lehmann
Applied Sciences (2024) Vol. 14, Iss. 23, pp. 11048-11048
Open Access
Association of systemic inflammation and long-term dysfunction in COVID-19 patients: a prospective cohort
Felipe Dal‐Pizzol, Bruno Kluwe‐Schiavon, Henrique Ritter Dal-Pizzol, et al.
Psychoneuroendocrinology (2024) Vol. 172, pp. 107269-107269
Closed Access
Page 1

Scroll to top